« Nouvelles insuffisances rénales »
Pierre Cochat(Société Nationale des Chemins de Fer Français (France)), A. Liutkus(Hôpital Femme Mère Enfant), I. Fauriel(Lyon 1 Université), Nathalie Guffon(Hôpital Edouard Herriot), Bruno Ranchin(Hospices Civils de Lyon), Laurence Dubourg(Lyon 1 Université)
Cited by 0
Related Papers
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
An estimated glomerular filtration rate equation for the full age spectrum
|Nephrology Dialysis Transplantation|2016|489
Development and Validation of a Modified Full Age Spectrum Creatinine-Based Equation to Estimate Glomerular Filtration Rate
|Annals of Internal Medicine|2020|400
Enzyme replacement therapy for mucopolysaccharidosis VI: A phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study
|The Journal of Pediatrics|2006|364